Akamai
AKAM
104.61
-4.01
-3.69%
Akamai
US · AKAM
#1115 by market cap
Listed 1970
104.61
-4.01
-3.69%
Live - 5344 symbols - heartbeat 122s ago
· 2026-10-08 08:38
Pre-market
103.99
-0.59%
After-hours
104.73
+0.11%
Overnight
103.13
-1.41%
- Market cap
- 15.03B
- P/E (TTM)i
- 37.90
- P/Bi
- 3.17
- EPSi
- 3.07
- Div yieldi
- 0.00%
- 52W posi
- 36%
Reader sentiment
Are you bullish or bearish on AKAM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.49, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +5.44% YoY
Margins
- Gross margin
- 58.95%
- Operating margin
- 14.93%
- Net margin
- 10.74%
Key ratios & quality
- Enterprise valuei
- 18.29B
- Altman Z-Scorei
- 2.49
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.71B | 2.89B | 3.20B | 3.46B | 3.62B | 3.81B | 3.99B | 4.21B |
| Gross profit | 1.76B | 1.91B | 2.07B | 2.19B | 2.23B | 2.30B | 2.37B | 2.48B |
| Selling & admin expenses | 982.78M | 947.55M | 966.70M | 918.98M | 984.11M | 1.06B | 1.10B | 1.15B |
| Research & development | 246.17M | 261.37M | 269.32M | 335.37M | 391.43M | 406.05M | 470.88M | 513.56M |
| Operating profit | 416.05M | 577.99M | 701.67M | 807.20M | 711.04M | 703.42M | 636.35M | 628.24M |
| Pretax profit | 343.09M | 532.48M | 616.08M | 728.22M | 658.00M | 652.53M | 587.01M | 602.41M |
| Tax | 44.72M | 53.35M | 45.92M | 62.57M | 126.70M | 106.37M | 82.10M | 150.37M |
| Net profit | 298.37M | 478.04M | 557.05M | 651.64M | 523.67M | 547.63M | 504.92M | 452.03M |
| Basic EPS | 2 | 3 | 3 | 4 | 3 | 4 | 3 | 3 |
| Diluted EPS | 1.76 | 2.90 | 3.37 | 3.93 | 3.26 | 3.52 | 3.27 | 3.07 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.02B | 1.04B | 1.05B | 1.09B | 1.07B | 1.10B |
| Gross profit | 596.19M | 616.96M | 625.10M | 642.41M | 602.31M | 613.75M |
| Selling & admin expenses | 272.33M | 290.52M | 288.50M | 303.21M | 302.38M | 335.37M |
| Research & development | 123.55M | 125.84M | 124.72M | 139.45M | 141.58M | 148.82M |
| Operating profit | 155.04M | 155.84M | 166.03M | 151.34M | 113.92M | 83.90M |
| Pretax profit | 173.38M | 151.94M | 173.17M | 103.92M | 122.00M | 100.03M |
| Tax | 50.21M | 48.32M | 33.00M | 18.85M | 15.68M | 20.62M |
| Net profit | 123.17M | 103.62M | 140.17M | 85.07M | 106.32M | 79.40M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.82 | 0.71 | 0.97 | 0.58 | 0.71 | 0.52 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.54B | 2.23B | 1.93B | 1.92B | 1.97B | 1.80B | 2.58B | 2.29B |
| Cash & ST investments | 1.89B | 1.54B | 1.10B | 1.08B | 1.11B | 864.44M | 1.60B | 1.19B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 5.46B | 7.01B | 7.76B | 8.14B | 8.30B | 9.90B | 10.37B | 11.48B |
| Total current liabilities | 1.21B | 693.34M | 758.17M | 790.34M | 818.87M | 836.04M | 2.09B | 967.52M |
| Short-term debt | 686.55M | 139.46M | 154.80M | 175.68M | 196.09M | 222.94M | 1.41B | 336.61M |
| Long-term debt | 874.08M | 1.84B | 1.91B | 1.98B | 2.29B | 3.54B | 2.40B | 4.11B |
| Total liabilities | 2,269,910,000.00 | 3,348,928,000.00 | 3,512,834,000.00 | 3,608,659,000.00 | 3,943,213,000.00 | 5,302,882,000.00 | 5,490,428,000.00 | 6,502,272,000.00 |
| Total equity | 3.19B | 3.66B | 4.25B | 4.53B | 4.36B | 4.60B | 4.88B | 4.98B |
| Retained earnings | -430.89M | 48.00M | 605.05M | 1.26B | 1.92B | 2.47B | 2.97B | 3.42B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.37B | 2.03B | 2.17B | 2.29B | 2.13B | 4.65B |
| Cash & ST investments | 1.32B | 966.62M | 1.12B | 1.19B | 930.45M | 3.36B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 9.98B | 10.54B | 10.83B | 11.48B | 11.65B | 15.07B |
| Total current liabilities | 2.02B | 880.52M | 950.32M | 967.52M | 1.04B | 2.84B |
| Short-term debt | 1.41B | 271.50M | 281.35M | 336.61M | 369.11M | 2.08B |
| Long-term debt | 2.40B | 4.10B | 4.10B | 4.11B | 4.11B | 5.86B |
| Total liabilities | 5,397,629,000.00 | 6,068,627,000.00 | 6,101,329,000.00 | 6,502,272,000.00 | 6,736,927,000.00 | 10,324,903,000.00 |
| Total equity | 4.58B | 4.47B | 4.73B | 4.98B | 4.91B | 4.75B |
| Retained earnings | 3.10B | 3.20B | 3.34B | 3.42B | 3.53B | 3.61B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.01B | 1.06B | 1.22B | 1.40B | 1.27B | 1.35B | 1.52B | 1.52B |
| Depreciation & amortization | 434.52M | 440.67M | 478.39M | 550.63M | 592.75M | 570.78M | 648.41M | 708.61M |
| Free cash flow | 602.59M | 496.23M | 483.13M | 859.33M | 816.37M | 618.40M | 833.90M | 699.27M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -750.00M | -334.52M | -193.59M | -522.26M | -608.01M | -654.05M | -557.47M | -799.96M |
| Ending cash balance | 1.04B | 394.15M | 353.47M | 537.75M | 543.02M | 490.47M | 519.08M | 931.31M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 251.20M | 459.15M | 441.83M | 366.58M | 312.51M | 326.27M |
| Depreciation & amortization | 174.02M | 175.46M | 176.62M | 182.51M | 183.75M | 185.54M |
| Free cash flow | 55.19M | 235.37M | 246.82M | 161.89M | 120.66M | 100.51M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -499.96M | -300.00M | 0 | 0 | -205.89M | -409.86M |
| Ending cash balance | 1.10B | 851.46M | 931.32M | 931.31M | 626.94M | 1.48B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.18 | 13.96 | 14.09 | 14.84 | 11.78 | 12.23 | 10.66 | 9.17 |
| ROA %i | 5.93 | 7.67 | 7.54 | 8.20 | 6.37 | 6.02 | 4.98 | 4.14 |
| ROIC %i | 6.64 | 8.87 | 8.89 | 9.76 | 7.10 | 6.30 | 4.74 | 4.19 |
| 5-year avg ROE %i | 9.71 | 10.11 | 10.80 | 11.75 | 12.75 | 13.38 | 12.72 | 11.74 |
| EBIT margin %i | 14.23 | 20.11 | 21.43 | 23.13 | 18.50 | 17.58 | 15.39 | 15.05 |
| FCF / sales %i | 22.20 | 17.15 | 15.11 | 24.83 | 22.57 | 16.22 | 20.89 | 16.62 |
| Current ratioi | 2.09 | 3.22 | 2.54 | 2.43 | 2.41 | 2.16 | 1.23 | 2.36 |
| Quick ratioi | 1.96 | 3.01 | 2.32 | 2.22 | 2.18 | 1.90 | 1.11 | 2.05 |
| Debt / assetsi | 28.57 | 38.13 | 35.77 | 35.13 | 38.23 | 45.82 | 44.70 | 49.44 |
| LT debt / equityi | 27.38 | 69.22 | 61.68 | 59.23 | 68.31 | 93.82 | 66.14 | 107.26 |
| Interest coveragei | 8.94 | 11.79 | 9.91 | 11.07 | 60.30 | 37.85 | 22.65 | 20.58 |
| Revenue CAGR (3Y) %i | 7.30 | 7.21 | 8.71 | 8.44 | 7.72 | 6.03 | 4.86 | 5.18 |
| Net income CAGR (3Y) %i | -2.45 | 14.23 | 35.73 | 29.74 | 3.09 | -0.57 | -8.15 | -4.79 |
| FCF CAGR (3Y) %i | 20.03 | -3.69 | 7.75 | 12.56 | 18.05 | 8.58 | -1.00 | -5.03 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.82 | 9.21 | 10.64 | 9.17 | 9.17 | 8.92 |
| ROA %i | 4.55 | 4.12 | 4.82 | 4.14 | 4.02 | 3.21 |
| ROIC %i | 4.36 | 4.04 | 4.86 | 4.19 | 4.07 | 3.07 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.91 | 14.34 | 16.59 | 15.05 | 13.67 | 12.26 |
| FCF / sales %i | 17.69 | 16.63 | 17.38 | 16.62 | 17.92 | 14.57 |
| Current ratioi | 1.18 | 2.31 | 2.28 | 2.36 | 2.06 | 1.64 |
| Quick ratioi | 1.03 | 1.98 | 1.98 | 2.05 | 1.75 | 1.52 |
| Debt / assetsi | 46.27 | 50.03 | 48.29 | 49.44 | 50.38 | 61.96 |
| LT debt / equityi | 69.92 | 111.91 | 104.60 | 107.26 | 112.01 | 152.95 |
| Interest coveragei | 22.15 | 20.67 | 23.56 | 20.58 | 18.08 | 17.07 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:38:26 · For reference only, not investment advice and not tailored to your situation.